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ABSTRACT
Objectives Stigma remains pervasive for people living
with HIV (PLHIV) in sub-Saharan Africa, undermining
care engagement. Using everyday, biographical and
epochal temporalities, we explored the manifestation of
stigma at different stages of the HIV care continuum in
seven health and demographic surveillance sites in
Eastern and Southern Africa.
Methods Between 2015 and 2016, we conducted
qualitative in-depth interviews with 264 PLHIV, 54
health providers and 48 family members of people who
had died from HIV. Topic guides explored experiences of
HIV testing, care and treatment services. Data were
analysed thematically, aided by NVivo 10.
Results In everyday time across these communities,
stigma was evident in the presence of gossiping and the
relative absence of supportive interpersonal discourse,
which fuelled judicious disclosure. This was especially
disruptive at testing, counselling and early antiretroviral
therapy adherence stages of care. Biographical time
framed everyday stigma events, highlighting the dilemma
of disclosure in relation to sexual relationship norms, as
well as the interfacing of age and healthcare continuum
points. Epochal patriarchal relations gave a structural
context to everyday and biographical stigma dynamics.
Historical shifts to social acceptance of PLHIV within
these communities, while positive, were complicated by
stigma in everyday life and in respect of biographical
goals like having a family. Moreover, low community-
level resistance to HIV-related stigma jeopardised stigma
reduction strategies.
Conclusions Despite improvements to HIV care
services, stigma remains pervasive across the HIV care
continuum in these sites. Context-speciﬁc interventions
are needed to address stigma and discrimination of
PLHIV within the community and in health services, and
greater reﬂection is required to ensure policies aiming to
expand HIV treatment do not exacerbate stigma and
result in negative HIV outcomes.
INTRODUCTION
Stigmatisation involves individual, cultural and
structural processes which, through the use of
power, combine to produce negatively valued dif-
ference.1 HIV-related stigma may hinder attempts
to eliminate AIDS by 2030.2 Therefore, the 2016
UN General Assembly Political Declaration on
Ending AIDS has set out a target of eliminating
HIV-related stigma and discrimination by 2020.
This ambitious target follows earlier hopes that
antiretroviral therapy (ART) roll-out would help
reduce stigma.3 4 However, public stigma—negative
attitudes and beliefs that the general public hold
towards people living with HIV (PLHIV)—remains
a signiﬁcant challenge across Africa.5 6 Moreover,
ART may have mixed effects on stigma reduction,
making the UN AIDS target problematic. For
instance, Roura et al7 noted the emergence of a
stigma paradox 2 years after ART availability in
rural Tanzania. On the one hand, PLHIV were seen
as less burdensome by themselves and others,
leading to decreased self-stigma (ie, internalising
public stigma) and increased social support, which
helped normalise HIV and increased voluntary
counselling and testing (VCT) uptake. This is sup-
ported by other studies from sub-Saharan Africa in
respect of decreasing public stigma8 and increasing
the coping skills of PLHIV.9 On the other, new
sources of stigma emerged whereby fears of sexual
transmission were exacerbated, fuelling moral
outrage, and a persistence in blame for being ‘irre-
sponsible’ in spreading the virus through sexual
activity abounded. This, in turn, led to widespread
anticipated stigma (ie, fear of being stigmatised),
othering and a collective denial that reduced VCT
uptake.
Most qualitative research exploring the relation-
ship between stigma and accessing HIV services has
focused on how it inﬂuences HIV testing
uptake.7 10–12 Few studies have explored the effect
of stigma on PLHIV’s engagement with HIV ser-
vices once diagnosed and expected to initiate ART,
and adhere to lifelong pill-taking and clinic
visits.13 14 Additionally, most stigma studies have
been quantitative rather than qualitative,11 15 16
often looking at public stigma5 6 rather than experi-
enced stigma (ie, the actual experience of discrimin-
ation or prejudice) and anticipated stigma among
PLHIV. Furthermore, stigma studies in the context
of ART roll-out have tended to focus on one
country.7 11 15 17 However, if HIV-related stigma is
going to be reduced, there is a need to understand
how stigma manifests and is experienced and antici-
pated at different stages of HIV care. Moreover, it
is imperative that this is understood across the
health service and policy contexts of different epi-
demics. Understanding the geographical and care
continuum manifestations of stigma enables anti-
stigma interventions to be more efﬁciently targeted.
Three overlapping stigma temporalities
Essential to this is having a nuanced understanding
of the temporality of stigma events. Stigma studies
focusing on the effect of ART on VCT stages tend
to have a singular view of time (ie, either before
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and after new treatment, or the point in time when testing
occurs), rather than one where overlapping modalities of time
effect the contexts and concerns of PLHIV. In contrast, this
paper uses three perspectives on time: everyday, biographical
and epochal.18 These are not philosophically discrete, detached
ways within which stigma dynamics play out, but imbricated
ones that ﬂow into and inﬂuence each other. An analytical
understanding of the role of time—in combination with social
and cultural structures and human agency—provides clues for
antistigma practices.
Everyday time concerns the description, immediacy and repe-
tition of daily stigma events. Some questions PLHIV might navi-
gate in everyday time are: How is HIV discussed day-to-day in
public spaces? Given what others know about me, will I experi-
ence stigma today if I socialise with friends?
Biographical time is slightly different to the quotidian repeti-
tion of everyday stigma. Pertinent questions here include: When
should people get tested for HIV during their lifetimes? When
and to whom should they disclose their status? Should they start
treatment when advised? The key question cutting through all
of these is ‘What is at stake within this and future biographical
moments—will my life chances and projects be limited in some
way if I am associated with HIV’?
Epochal or historical time relates to whether conditions inﬂu-
encing HIV-related stigma are stable and enduring, or elaborated
and transformed. So, for instance, is gossiping about PLHIV a
practice that is being observed less nowadays than in the past?
Are communities uniﬁed and enabled to challenge stigma, or is
stigma resistance still sporadic and individualised? How have
developments in treatment availability and coverage inﬂuenced
the level and nature of stigmatising interactions?
Using these temporalities, we aim to investigate how
HIV-related stigma manifests in PLHIV’s accounts of their HIV
care across seven rural locations in six sub-Saharan African
countries and how these experiences shape their treatment
engagement.
METHODS
Settings and sample
This paper draws upon qualitative data from in-depth interviews
conducted in a multicountry study (the ‘Bottlenecks’ study)
exploring the interaction of PLHIV and HIV care services.
Additional methodological details concerning the Bottlenecks
study can be found in the online methods supplement found
within the editorial http://dx.doi.org/10.1136/sextrans-2017-
053172.19 Ethical approval was obtained from London School of
Hygiene & Tropical Medicine (LSHTM) (Ref: 10389) and by
local ethics boards at the study locations. Informed and written
consent was obtained from all participants. The study took place
in Karonga (Malawi), Rakai and Kyamulibwa (Uganda), Kisesa
(Tanzania), Kisumu (Kenya), Manicaland (Zimbabwe) and
uMkhanyakude (South Africa). Through health and demographic
surveillance site (HDSS) datasets and ART clinics, we purposively
sampled 264 PLHIV and 48 family members of deceased people
with HIV to achieve a broad distribution of sex, age and care
history. Family members were identiﬁed through HDSS verbal
autopsy reports. Additionally, 54 healthcare workers were purpos-
ively sampled across the sites to ensure a range of perspectives on
the provision of HIV services from different cadres (see table 1).
Further information can be found in the online supplementary
ﬁle.
Data collection and analysis
Fieldworkers were trained in each location. They administered a
short screening tool before conducting each in-depth interview
to ensure participant eligibility and to obtain diagnosis and
treatment history of PLHIV. Face-to-face in-depth interviews,
conducted in local languages, were chosen owing to the sensi-
tive and personal nature of information being discussed. Topic
guides for PLHIV explored experiences of interactions with
healthcare services throughout the care continuum, the salience
of community health issues and HIV-related stigma. Some
repeat interviews were done to build rapport and discuss more
sensitive issues. Interviews with family members of the deceased
focused on the circumstances that contributed to their loved
ones’ deaths. Healthcare provider interviews solicited reﬂections
on engaging PLHIV and delivering HIV services. Details of how
these topics were generated can be found in the online-only
supplement. Interviews lasted approximately 45–90 min and
took place in participants’ homes or private clinic areas. Data
were collected between October 2015 and April 2016.
Interviews were audio-recorded, then anonymised, and either
summarised into detailed reports (Kyamulibwa) or transcribed
(Karonga, Kisesa, Rakai, Kisumu, Manicaland, uMkhanyakude)
and translated into English. Summaries were done in
Kyamulibwa due to researchers at this site being historically
trained in this method. All data were stored in secure password-
protected locations. Participants were recruited until thematic
saturation was reached.
A latent thematic analysis was conducted, which entails a
process of identifying and analysing patterns within qualitative
data beyond surface meanings.20 A broad analytical framework
Table 1 Description of study participants by site
Person living with HIV
Country HDSS HCW Never ART On ART LTFU† Family member of deceased
Uganda Rakai 6 15 15 6 8
Uganda Kyamulibwa 5 8 16 4 5
Kenya Kisumu 8 10 15 6 11
Tanzania Kisesa 7 13 14 4 6
Malawi Karonga 5 9 27 4 6
Zimbabwe Manicaland 4 16 35 8 6
South Africa uMkhanyakude 19 16 17 6 6
Total 54 87 139 38 48
†Lost to follow up from a HIV clinic for >90 days;
ART, antiretroviral therapy; HCW, healthcare Worker; HDSS, health and demographic surveillance sites; LTFU, lost to follow up.
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for coding stigma-related issues within the dataset was estab-
lished by OB, based on inductive coding of randomly selected
transcripts and deductive categories derived from general stigma
theory and speciﬁc concepts (anticipated stigma, public stigma,
experienced stigma and self-stigma), as deﬁned above.1 This was
initially populated and adapted by site coordinators who coded
their site’s data with the aid of NVivo 10. OB then conducted a
further layer of deductive coding on the superordinate stigma
themes from each site to analyse them in respect of the afore-
mentioned temporal perspectives. Ongoing data analysis, emer-
ging hypotheses and the analytical approach were discussed
with site coordinators during regular meetings.
RESULTS
Stigma in everyday time
Across the sites, stigma within the daily routines and repetitive
dilemmas of PLHIV’s lives included: (1) the immediate presence
of stigma in everyday situations, manifest as repeated gossiping,
mocking and laughing, and (2) the relative absence of supportive
interpersonal discourse, which fuelled information management
and judicious disclosure.
The presence of stigma, across the sites, typically materialised
in anticipated gossiping, though numerous examples of experi-
enced gossiping existed too. While some PLHIV ignored com-
munity gossip and engaged in care, for others, its insidiousness
inﬂuenced their termination or intermittence of treatment:
After the test I was told that I have the virus and I accepted it. I
went back home and when we were bathing in the rivers I was
sickly and they laughed at me. You see, this made me stop treat-
ment. (Male, PLHIV, on ART, Zimbabwe)
Public stigma (occasionally enacted by healthcare workers)
disrupted PLHIV’s transitioning throughout the care and treat-
ment continuum, but especially during testing and early coun-
selling, and also initial ART adherence. Central to fear of gossip
was the lack of privacy and conﬁdentiality experienced daily at
community clinics and hospitals.
How will they [neighbours] regard me being in the queue there,
on the bench waiting for the medicines, or when I’ve gone for
testing…how will they think of me? (Male, PLHIV, on ART,
Tanzania)
Fear of gossiping and mocking prompted some PLHIV to
retreat from clinics or travel long distances to those far away
from their communities:
I come to a far away clinic, no one will know that I have come
here to take drugs. (Female, PLHIV, on ART, Kenya)
Stigma in biographical time
Biographical time frames everyday stigma events to highlight the
dilemma of disclosure in relation to sexual relationship norms,
as well as the interfacing of age and healthcare continuum
points.
Disclosure and relationships
The dilemma of disclosure within—and its threat to—heterosex-
ual and marital relations, especially for younger people, was
vexed and salient. One young Ugandan woman recounted: ‘If
you had no man, you wouldn’t get anyone [if they knew your
status]. If someone loved you, [your friends] would say to them,
“that one is sick”’. This issue complicated couple-testing policies
at each location.
They [pregnant women] are all accepting to get tested. We have a
few problems where they do not want to get tested or after
getting tested they do not want their results. If that person takes
the results she might refuse to take treatment… this is mostly
done by the young mothers who have recently got married. They
are afraid to test positive and afraid to tell their husbands…afraid
that the marriage might be broken. (Healthcare worker,
Zimbabwe)
Within the sample, complete and ongoing concealment in
interpersonal relationships was rare. Yet, disclosure was individ-
ual and time-sensitive, a biographical step-change that was risky
across relationships. Potential social support from partners,
friends, family and neighbours, often forthcoming consequent
upon disclosure, simultaneously posed a risk of discrimination
and blame:
After ﬁnding out that I was positive, and my sister in law scolding
me, I saw that it was better someone dies rather than feeling the
pain of being rudely talked to. (Female, PLHIV, on ART, Kenya)
That said, when some PLHIV did not disclose, they continued
to hear negative comments from their loved ones about PLHIV,
became alienated from other PLHIV and sometimes missed
clinical appointments:
The person I stay with—my mother in law—I have not disclosed
to her. So ﬁnding time to come here [clinic] is a bit difﬁcult, so
most of the times I come late, at times I miss coming. (Female,
PLHIV, on ART, Kenya)
We still have a problem especially us young males, even me.
Before I tested positive…I didn’t like someone who is HIV posi-
tive. I remember when another guy disclosed his status, while we
were busy eating meat, I chose to stop eating with them. What I
used to see is people are talking badly about HIV even though
they are HIV positive. Now I can see why they do that; they
want to protect their names from being known that they are HIV
positive. (Male, PLHIV, on ART, South Africa)
Family members tended to offer most support to PLHIV after
disclosure, across the sites. However, some PLHIV only dis-
closed to partners, especially when there was family discord.
Indeed, PLHIV sometimes concealed their diagnosis and treat-
ment from their family members even after ART initiation.
Age and HIV care experience
The second way biographical time contextualised everyday
stigma events was in respect of age and point along the care and
treatment continuum. In this respect, gossiping was less affecting
for those over 40 and those more stable on ART, perhaps
because some goals (eg, courtship and reproduction) had
already been achieved. That said, some older people were mar-
ginalised and considered already dead by their family members.
A healthcare worker in Kisesa recounted an older woman’s
experience:
After further encouragement, her family members visited, they
refused to be supportive and started to divide the old woman’s
possessions as she watched…They told her they will stay distant
until she passes away then take her remaining possessions.
Moreover, some older people reported unease at clinics
where they were often outnumbered by younger people whom,
they imagined, speculated about their sexual activity:
We old people mix with children there [hospital]… people tend
to think about how we old people got infected with this disease.
(Male, PLHIV, on ART, Malawi)
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Stigma in epochal time
Epochal patriarchal relations gave a structural context to every-
day and biographical stigma dynamics. Historical shifts to social
acceptance of PLHIV within these communities, while positive,
were complicated by stigma in everyday life and in respect of
biographical goals like having a family. Moreover, low
community-level resistance to HIV-related stigma, and contra-
dictory strategies, such as integrating or separating patients with
HIV in clinics, jeopardised and confused stigma reduction
strategies.
Patriarchy
In combination with a reluctance to disclose, men were often
able to mobilise patriarchal structures to avoid testing, whether
alone or part of a couple.
Interviewer: Did you test together with your husband?
Participant: No, he does not allow, he does not accept. He does
not tell me. I got this feeling that he is like me [HIV+] but fears
to tell me. (Female, PLHIV, diagnosed not in care, Uganda)
Moreover, men often insisted that their partners get tested
and disclose ﬁrst, which they used to absolve themselves from
any part in bringing HIV into relationships. HIV-positive
women sometimes hid their status or stopped pill-taking for
fear of domestic abuse or divorce. One young woman in
Karonga, on ART while pregnant, hid her ARVs in a bag of
ﬂour, scared that her husband would have beaten her up or even
killed her if he had discovered her status.
Normalisation?
Notwithstanding enduring issues of patriarchy, there were signs
of increasing social acceptance of HIV over historical time
within these communities. HIV was acknowledged as wide-
spread, even ‘normal’, and no longer viewed uniformly as a
death sentence in the age of ART; many participants were ‘not
shocked’ at being diagnosed.
I just felt normal about having [AIDS], like it was a normal thing
because it’s not just me who has it…why would I be shocked? It
has become a disease for everyone. (Female, PLHIV, on ART,
Tanzania)
There were suggestions that marginalisation of HIV was
decreasing across these communities. While any historical
decline of marginalisation might seem positive, it runs in
tandem with the persistence and power of everyday gossiping
and laughing mentioned above.
Each household where there is person living with HIV, those
people accept it, they understand now. But where there is no one
with HIV they see it as a joke. (Female, PLHIV, Diagnosed but
not on ART, Zimbabwe)
Indeed, some of participants’ discourse suggested a hope for
idealised situation rather than an experienced reality. Relatedly,
some PLHIV who described this epochal shift to social accept-
ance simultaneously struggled with disclosure. Also, some
healthcare workers went so far as to claim that ‘currently there
is no stigma’ (Karonga) in their communities allowing people to
test more freely. Yet, this view sometimes contrasted markedly
with the daily experiences of PLHIV, shown above.
Challenging stigma?
Community-level challenges to stigma remain low and fragmen-
ted across all sites, suggesting epochal stasis, due to a lack of
resources. Support most often came privately from immediate
family and friends:
My husband, once I had told him… he was the one who advised
me to just come and take drugs, that it was good. (Female,
PLHIV, on ART, Kenya)
That said, some older PLHIV reported instances of commu-
nity members being ﬁned and sanctioned for gossiping (eg, in
Malawi, Zimbabwe, Uganda), and there were a few examples of
local opinion leaders organising well-attended public HIV
discussions:
Church leaders, like priests and catechists, preached against com-
munity stigma in their communities. (Healthcare worker,
Uganda)
In the current epoch, increased visibility of HIV-related
activities in the community can have both positive and nega-
tive effects on stigma. For example, integrated healthcare ser-
vices were considered by some PLHIV and healthcare workers
as destigmatising in Kyamulibwa (because it reduced ‘other-
ing’), but stigmatising in Kisesa and Karonga (because of lack
of privacy).
We mixed HIV patients with general ones because of stigma.
Patients were afraid of being seen coming from the counselling
room. (Healthcare worker, Uganda)
DISCUSSION
Within these communities, HIV-related stigma persists in every-
day, biographical and epochal time. These temporal framings
shed light on why PLHIV cycle in and out of care,21 why the
2020 UN stigma reduction target is ambitious2 and why stigma
persists in the age of ART.7
Everyday stigma events included gossiping, laughing and
mocking from community members, and relatively absent sup-
portive community HIV-related discourse. This contributed to
delayed uptake of testing7 12 and intermittent postdiagnosis care
engagement, supporting ﬁndings from other recent single-
country15 17 22 and multicountry23 24 analyses. Continued
public concealment of seropositivity, especially during earlier
stages of care, inﬂuences the absence of tolerant discourse.
However, few PLHIV disclosed to no one, as has been
observed elsewhere.24 The absence of constructive discussion
of HIV in public spheres has previously been reported by
Campbell et al25 in South Africa. When gossip is the main
presence of HIV discourse in public life, it restricts the daily
support for PLHIV. Moreover, persisting forms of everyday
stigma frustrate the biographical goal of HIV stabilisation and
the epochal one of AIDS elimination. Private support within
families and friendships has enabled greater acceptance, but
this needs to translate into everyday advocacy and accepting
discourses in public too.26 Healthcare staff, policy-makers and
community leaders should help PLHIV understand everyday
experiences of stigma in light of wider epochal shifts to social
acceptance; where PLHIV are unable to detect these changes
in their everyday lifeworlds, then their care engagement may
be undermined.
Biographical time, especially in respect of pressures to
partake in socially and sexually important projects and prac-
tices, contextualises why everyday stigma events are important
throughout the life course and at different points along the
care and treatment continuum, particularly during testing and
ART adherence. Healthcare workers and policy-makers must
recognise the importance of HIV-related stigma to
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biographical life goals, such as sexual relationships and child-
rearing, and work with PLHIV and their partners to ﬁnd
accepting solutions.
The ﬁnding that HIV-related stigma is affected by epochally
persisting gender and socioeconomic inequalities, within these
communities, reﬂects earlier studies17 22 and indicates the
importance of challenging structural stigma in respect of endur-
ing relations of poverty. It should be acknowledged that disclos-
ure in patriarchal and sexist contexts may not be of beneﬁt to
PLHIV.27 Interventions need to be targeted at gender structures5
and different age groups throughout the life course and speciﬁc
community contexts. Our ﬁndings also mirror those of Church
et al28 who noted the complex relationship between models of
HIV care (stand-alone or integrated) and stigma; practical guid-
ance for healthcare workers to minimise stigma across the differ-
ent models is therefore needed. Notwithstanding the effect of
these epochally entrenched and complex conditions on
HIV-related stigma, it appears a combination of successful
health education, improvements to health services and the pro-
vision of ART9 has partially tackled HIV-related stigma and
helped normalise HIV.15 To go further, there is a great need for
village leaders and clinical staff to be supported—ﬁnancially,
legally and normatively—to innovate new ways of generating
community discussion and informing policy. Moreover, HIV
healthcare should be delivered through ﬂexible community out-
reach, and engagement techniques should be developed for
those who may avoid such visits for fear of being exposed as
HIV-positive to neighbours. To insist that PLHIV attend clinics
to obtain treatment is to fail to acknowledge the importance of
stigma in everyday, biographical and epochal time: the conse-
quence can be that PLHIV wait until they are desperate or die
before they get help.
Intractable epochal structures that facilitate stigma, or make
no inroads into its mitigation, need to be tackled by a concerted
collective effort, which policy-makers need to be part of.
Central to this will be investment in community, national and
international interventions to destigmatise. As social contact
interventions, in the context of improving HIV-related educa-
tion, appear to offer optimistic avenues for HIV-related stigma
reduction,29–31 there is a need to continue health education
efforts and create considered public interactions between those
infected and those who are not across these communities.
Our study has several strengths and limitations. Experienced,
local research teams and access to HDSS databases enhanced
recruitment and data collection of PLHIV, especially those who
were no longer in care. While the generalisability of our ﬁndings
is limited by the small sample size, cross-country analysis
showed a considerable commonality across the research sites,
which may be generalisable to other rural populations in
sub-Saharan Africa. Participants had some difﬁculty discussing
sensitive issues and experiences; however, this was minimised by
ensuring conﬁdentiality and by using trained, local interviewers
of different genders and ages who avoided judgemental reac-
tions. People experiencing most extreme or violent forms of
stigmatisation were perhaps most likely to be under-represented
in the study, for example, those lost to follow-up.
CONCLUSION
Future HIV-related stigma research would beneﬁt from being
sensitive to temporality. Consideration of this allows a multifa-
ceted view of HIV-related stigma to emerge throughout the care
and treatment continuum, across epidemics. Stigma certainly
disrupts testing, but it can also lead to intermitting or terminat-
ing postdiagnosis care. In light of historical, biographical and
daily persistence of stigma events, there is an urgent need to
develop tailored healthcare plans for PLHIV, and for greater
investment in stigma mitigation.
Key messages
▸ A novel temporal framing of HIV-related stigma dynamics
can usefully situate and interpret experiences of people
living with HIV (PLHIV) across the HIV care continuum.
▸ Everyday time frames HIV-related stigma to show the
repetitive presence of gossiping and mocking, but also the
relative quotidian absence of supportive interpersonal
discourse in public life across these communities.
▸ Biographical time frames everyday stigma events,
highlighting the dilemma of disclosure in relation to sexual
relationship norms, as well as the interfacing of age and
healthcare continuum points.
▸ Epochal time shows the importance of persisting patriarchy
to stigma experience. There are, however, signs of increasing
social acceptance of PLHIV over historical time within these
communities.
▸ There is a great need to focus resources on multilevel
resistance to HIV-related stigma that takes account of
imbricated temporalities.
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